U.S. based monkeypox vaccine manufacturer targets December for first batch of doses for delivery.
The FDA lifts partial clinical hold on Curis' (CRIS) phase I/II TakeAim lymphoma study investigating emavusertib in patients with B-cell malignancies. Shares surge.
Two of these stocks together generate more than $1.6 billion in annual dividend income for Berkshire Hathaway.